Supplementary files for- Immune-mediated hepatic disorders associated with tyrosine kinase inhibitors plus immunotherapy in renal cell carcinoma

Supplementary file S1: Raw data of immune-mediated hepatic disorders associated with TKI plus IC combination therapy. Supplementary file S2: Raw data of drug-drug interactions analysis between TKI and ICI combination therapy.

补充文件S1：酪氨酸激酶抑制剂（Tyrosine Kinase Inhibitor，TKI）联合免疫检查点抑制剂（Immune Checkpoint Inhibitor，ICI）治疗相关免疫介导性肝脏疾病原始数据。补充文件S2：酪氨酸激酶抑制剂与免疫检查点抑制剂联合治疗的药物相互作用分析原始数据。